New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...

GoPath Diagnostics, a leading provider of molecular and digital pathology services, today announced the launch of DiabetesNow ...

Biomea Fusion (BMEA) announced the presentation of new preclinical and clinical data for icovamenib, the company’s ...

A new study has found a link between certain midlife vascular risk factors — specifically high blood pressure, diabetes, and ...

This Review briefly outlines the pathophysiology of type 1 diabetes mellitus and discusses therapeutic targets that have reached clinical trials, including immunotherapy, and how these treatments ...

Diabetes is increasing due to obesity and lack of exercise, and if type 2 diabetes patients are accompanied by mental illness ...

Patients are usually treated by insulin-replacement therapy. This Review briefly outlines the pathophysiology of type 1 diabetes mellitus and discusses therapeutic targets that have reached ...

InMed stock jumped after preclinical data showed INM-901 lowered brain inflammation tied to Alzheimer's and improved ...

In a rodent model of type 2 diabetes (T2D), icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and b ...

Zhejiang University School of Medicine in China, along with American researchers, has found no link between late-life intake ...

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce the successful de ...

Oct. 2, 2024 — People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low -- from taking too much insulin or not eating enough sugar -- people can ...